News & Blog

Tag Archives: FDA

What the Brain Tumor Community Was Reading in 2017

This year we covered many topics on this blog, from stories of strength, determination, and dedication in the community; to news on research progress; clinical trial results and updates; innovation; and FDA approvals. We saw glioblastoma again enter the national consciousness, with the unfortunate news of Senator John McCain’s diagnosis (see below), as well as some […]

Top Five Blogs: July – September 2017

July and August are prime months to get away for a break, relax, and enjoy the summer vacation season. And September welcomes everyone back to the ‘real world’ of school, sports, and normal work schedules. While unfortunetly, we can’t afford to ‘take a break’ in the brain tumor community – just as patients and caregivers […]

Potential Glioblastoma Treatments Entering The Pivotal Phase of Evaluation

Jump Ahead to List of Trials Glioblastoma (GBM) is the most common and aggressive malignant brain tumor and, regrettably, very limited treatment options exist for these patients. The current standard-of-care for newly diagnosed patients is surgery, followed by radiation and chemotherapy (with temozolomide), and, in some cases, use of the tumor-treating-field device, Optune. If and […]

Share